SCOPUS 정보 검색 플랫폼

European Journal of Cancer and Clinical Oncology

Volumn 26, Issue 11-12, 1990, Pages 1133-1136

Quality of life and treatment of hormone resistant metastatic prostatic cancer

(7) Fosså, Sophie D a Aaronson, Neil K b Newling, Don c van Cangh, P J d Denis, Louis f Kurth, Karl Heinz g de Pauw, Marleene e

a OSLO UNIVERSITY HOSPITAL (Norway)

b NETHERLANDS CANCER INSTITUTE (Netherlands)

c PRINCESS ROYAL HOSPITAL (United Kingdom)

d CLINIQUES UNIVERSITAIRES SAINT LUC (Belgium)

e EORTC DATA CENTER (Belgium)

f Academic Hospital Middelheim (Belgium)

g ACADEMIC MEDICAL CENTER (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRAMUSTINE; MITOMYCIN C;

ARTICLE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DRUG RESISTANCE; ESTRAMUSTINE; HORMONES; HUMAN; MALE; MITOMYCINS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0025695962 PISSN: 02775379 EISSN: None Source Type: Journal
DOI: 10.1016/0277-5379(90)90269-Y Document Type: Article

Times cited : (137)

References (17)

1
- 0021796372
- A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma
- (1985) J Clin Oncol , vol.3 , pp. 827-841
- Eisenberger¹ Simon² O'Dwyer³ Wittes⁴ Friedman⁵

2
- 0023729149
- Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs
- (1988) Semin Oncol , vol.15 , pp. 371-389
- Raghaven¹

3
- 33644637178
- Second line treatment in prostatic cancer: hormonal and cytostatics
- HJG Bloom, IWF Hanham, Wiley, Chichester
- (1988) Urological Oncology: Dilemmas and Development
- Fosså¹

4
- 0002796619
- Multidimensional approach to the measurements of quality of life in lung cancer clinical trials
- NK Aaronson, Backmann, Raven Press, New York
- (1987) The Quality of Life of Cancer Patients , pp. 63-86
- Aaronson¹ Bakker² Stewart³

5
- 0024358993
- Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer
- (1989) Eur Urol , vol.16 , pp. 335-350
- Fossà¹ Aaronson² da Silva³

6
- 0023855362
- Estimating the quality of life in clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the functional living index-cancer
- (1988) Cancer , vol.61 , pp. 849-856
- Ganz¹ Haskell² Figlin³ La Soto⁴ Siau⁵

7
- 0024441938
- Assessing quality of life in cancer patients
- (1989) Br J Cancer , vol.60 , pp. 437-440
- Maguire¹ Selby²

8
- 0024535895
- Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response
- (1989) J Clin Oncol , vol.7 , pp. 590-597
- Tannock¹ Gospodarowicz² Meakin³ Panzarella⁴ Stewart⁵ Rider⁶

9
- 85069405098
- Fosså SD, Aaronson N, and the members of the EORTCC GU Group. Treatment aims in hormone-resistant prostatic cancer. In: Oncology: Present and Future (Pais 131189). Proceedings (in press).

10
- 0023258134
- Buserelin treatment of advanced prostatic carcinoma
- Cancer
- (1982) Long-term follow-up of antitumor responses and improved quality of life , vol.59 , pp. 1713-1716
- Presant¹ Soloway² Klioze³

11
- 0024247237
- How would you like to have an orchiectomy for advanced prostatic cancer?
- (1988) Am J Clin Oncol , vol.11 , pp. S160-S168
- Parmar¹ Phillips² Lightman³ Edwards⁴

12
- 0024557878
- Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective double-blind, placebo-controlled study
- (1989) J Urol , vol.141 , pp. 85-87
- Smith¹

13
- 84944654856
- Functional Health status levels of primary care patients
- (1983) JAMA , vol.249 , pp. 3331-3338
- Nelson¹ Conger² Douglass³

14
- 0023864136
- Who should measure quality of life the doctor or the patient?
- (1985) British Journal of Cancer , vol.57 , pp. 109-112
- Slevin¹ Plant² Lynch³ Drinkwater⁴ Gregory⁵

15
- 85069407338
- Lack of correlation of patient (PT) and health care provider (HCP) ratings of cancer pain severity
- (1990) Proc ASCO , vol.9 , pp. 338
- Grossman¹ Sheidler² Swedeen³ Mucinski⁴ Piantadosi⁵

16
- 0020562770
- Impact of divergent evaluations by physicians and patients' complaints
- (1983) Public Health Rep , vol.98 , pp. 141-145
- Wartman¹ Morlock² Malitz³ Palm⁴

17
- 85069415826
- Newling D, Fossà SD, Tunn U, Kurth KH. The comparison of the effects of high dose estramustine phosphate and mitomycin C on the time to progressive, advanced endocrine independent prostatic cancer: an analysis of EORTC GU Group Study No. 30865. J Steroid Biochem (in press).

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.